197 related articles for article (PubMed ID: 27764251)
1. Heterologous Expression and Delivery of Biologically Active Exendin-4 by Lactobacillus paracasei L14.
Zeng Z; Yu R; Zuo F; Zhang B; Peng D; Ma H; Chen S
PLoS One; 2016; 11(10):e0165130. PubMed ID: 27764251
[TBL] [Abstract][Full Text] [Related]
2. Recombinant Lactococcus lactis expressing bioactive exendin-4 to promote insulin secretion and beta-cell proliferation in vitro.
Zeng Z; Yu R; Zuo F; Zhang B; Ma H; Chen S
Appl Microbiol Biotechnol; 2017 Oct; 101(19):7177-7186. PubMed ID: 28828521
[TBL] [Abstract][Full Text] [Related]
3. B-cell translocation gene 2 positively regulates GLP-1-stimulated insulin secretion via induction of PDX-1 in pancreatic β-cells.
Hwang SL; Kwon O; Kim SG; Lee IK; Kim YD
Exp Mol Med; 2013 May; 45(5):e25. PubMed ID: 23703573
[TBL] [Abstract][Full Text] [Related]
4. Delivery of two-step transcription amplification exendin-4 plasmid system with arginine-grafted bioreducible polymer in type 2 diabetes animal model.
Kim PH; Lee M; Kim SW
J Control Release; 2012 Aug; 162(1):9-18. PubMed ID: 22705459
[TBL] [Abstract][Full Text] [Related]
5. Exendin-4 promotes liver cell proliferation and enhances the PDX-1-induced liver to pancreas transdifferentiation process.
Aviv V; Meivar-Levy I; Rachmut IH; Rubinek T; Mor E; Ferber S
J Biol Chem; 2009 Nov; 284(48):33509-20. PubMed ID: 19755420
[TBL] [Abstract][Full Text] [Related]
6. Durable islet effects on insulin secretion and protein kinase A expression following exendin-4 treatment of high-fat diet-fed mice.
Winzell MS; Ahrén B
J Mol Endocrinol; 2008 Feb; 40(2):93-100. PubMed ID: 18234911
[TBL] [Abstract][Full Text] [Related]
7. Purification and bioactivity of exendin-4, a peptide analogue of GLP-1, expressed in Pichia pastoris.
Zhou J; Chu J; Wang YH; Wang H; Zhuang YP; Zhang SL
Biotechnol Lett; 2008 Apr; 30(4):651-6. PubMed ID: 18060365
[TBL] [Abstract][Full Text] [Related]
8. Effects of exendin-4 on glucose tolerance, insulin secretion, and beta-cell proliferation depend on treatment dose, treatment duration and meal contents.
Arakawa M; Ebato C; Mita T; Hirose T; Kawamori R; Fujitani Y; Watada H
Biochem Biophys Res Commun; 2009 Dec; 390(3):809-14. PubMed ID: 19836346
[TBL] [Abstract][Full Text] [Related]
9. Over-expression of the glucagon-like peptide-1 receptor on INS-1 cells confers autocrine stimulation of insulin gene promoter activity: a strategy for production of pancreatic beta-cell lines for use in transplantation.
Chepurny OG; Holz GG
Cell Tissue Res; 2002 Feb; 307(2):191-201. PubMed ID: 11845326
[TBL] [Abstract][Full Text] [Related]
10. Evidence for paracrine/autocrine regulation of GLP-1-producing cells.
Kappe C; Zhang Q; Holst JJ; Nyström T; Sjöholm A
Am J Physiol Cell Physiol; 2013 Nov; 305(10):C1041-9. PubMed ID: 23986202
[TBL] [Abstract][Full Text] [Related]
11. The role of clusterin on pancreatic beta cell regeneration after exendin-4 treatment in neonatal streptozotocin administrated rats.
Kaya-Dagistanli F; Ozturk M
Acta Histochem; 2013 Jul; 115(6):577-86. PubMed ID: 23351716
[TBL] [Abstract][Full Text] [Related]
12. The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells.
Ligumsky H; Wolf I; Israeli S; Haimsohn M; Ferber S; Karasik A; Kaufman B; Rubinek T
Breast Cancer Res Treat; 2012 Apr; 132(2):449-61. PubMed ID: 21638053
[TBL] [Abstract][Full Text] [Related]
13. Glucagon-like peptide-1.
Doyle ME; Egan JM
Recent Prog Horm Res; 2001; 56():377-99. PubMed ID: 11237222
[TBL] [Abstract][Full Text] [Related]
14. Suppression of Pdx-1 perturbs proinsulin processing, insulin secretion and GLP-1 signalling in INS-1 cells.
Wang H; Iezzi M; Theander S; Antinozzi PA; Gauthier BR; Halban PA; Wollheim CB
Diabetologia; 2005 Apr; 48(4):720-31. PubMed ID: 15756539
[TBL] [Abstract][Full Text] [Related]
15. Lactobacillus delivery of bioactive interleukin-22.
Lin Y; Krogh-Andersen K; Hammarström L; Marcotte H
Microb Cell Fact; 2017 Aug; 16(1):148. PubMed ID: 28830549
[TBL] [Abstract][Full Text] [Related]
16. Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro.
Parkes DG; Pittner R; Jodka C; Smith P; Young A
Metabolism; 2001 May; 50(5):583-9. PubMed ID: 11319721
[TBL] [Abstract][Full Text] [Related]
17. Oral delivery of bioencapsulated exendin-4 expressed in chloroplasts lowers blood glucose level in mice and stimulates insulin secretion in beta-TC6 cells.
Kwon KC; Nityanandam R; New JS; Daniell H
Plant Biotechnol J; 2013 Jan; 11(1):77-86. PubMed ID: 23078126
[TBL] [Abstract][Full Text] [Related]
18. Oral delivery of an anti-diabetic peptide drug via conjugation and complexation with low molecular weight chitosan.
Ahn S; Lee IH; Lee E; Kim H; Kim YC; Jon S
J Control Release; 2013 Sep; 170(2):226-32. PubMed ID: 23747732
[TBL] [Abstract][Full Text] [Related]
19. [Preparation and the biological effect of fusion protein GLP-1-exendin-4/ IgG4(Fc) fusion protein as long acting GLP-1 receptor agonist].
Zheng YC
Yao Xue Xue Bao; 2015 Dec; 50(12):1668-72. PubMed ID: 27169293
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular side-effects and insulin secretion after intravenous administration of radiolabeled Exendin-4 in pigs.
Rydén A; Nyman G; Nalin L; Andreasson S; Velikyan I; Korsgren O; Eriksson O; Jensen-Waern M
Nucl Med Biol; 2016 Jul; 43(7):397-402. PubMed ID: 27179248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
